| . | All (%) . | AORCA (%) . | AOLCA (%) . | Other (%) . | P-value . |
|---|---|---|---|---|---|
| Follow-up completeness | 138/156 (88.5) | 91/105 (86.7) | 32/35 (91.4) | 14/16 (100) | NS |
| Alive | 133/156 (86.4) | 89/105 (84.8) | 31/35 (88.6) | 13/16 (81.3) | NS |
| Lost | 18/156 (11.5) | 17/105 (16.2) | 3/35 (8.6) | 1/16 (12.5) | NS |
| Age (years) | 38 (18–54.5) | 42 (20–53)a | 25 (17–53)b | 53 (17.5–57.5) | 0.020 |
| Presence of symptoms | 24/133 (14.2) | 17/89 (19.1) | 3/31 (9.7) | 4/13 (30.8) | NS |
| Chest pain | 10/133 (7.5) | 8/89 (9.0) | 2/31 (6.5) | 0/13 (0) | NS |
| Dyspnoea | 3/133 (2.3) | 3/89 (3.4) | 0/31 (0) | 0/13 (0) | NS |
| Fatigue | 3/133 (2.3) | 2/89 (2.2) | 0/31 (0) | 1/13 (7.7) | NS |
| Syncope | 1/133 (0.8) | 0/89 (0) | 0/31 (0) | 1/13 (7.7) | NS |
| Palpitations | 1/133 (0.8) | 0/89 (0) | 1/31 (3.2) | 0/13 (0) | NS |
| Vertigo/discomfort | 1/133 (0.8) | 1/89 (1.1) | 0/31 (0) | 0/13 (0) | NS |
| Not specified | 5/133 (3.8) | 3/89 (3.4) | 0/31 (0) | 2/13 (0) | NS |
| Sport activity | 64/133 (48.1) | 45/89 (50.6) | 12/31 (38.7) | 7/13 (53.8) | NS |
| Time of follow-up (years), min–max | 2 (1–5) [0–23] | 2 (1–4)a [0–8] | 5 (2–11)b [0–23] | 1 (0–5.5) [0–9] | 0.001 |
| NYHA ≥II at follow-up | 13/133 (9.8) | 8/89 (9.0) | 3/31 (9.7) | 2/13 (15.4) | NS |
| Adverse events | 12/133 (9.0) | 7/89 (7.9) | 1/31 (3.2)a | 4/13 (30.8)b | 0.086 |
| Cardiac interventional procedure | 6/133 (4.5) | 4/89 (4.5) | 0/31 (0) | 2/13 (15.4) | NS |
| Surgical reinterventional procedure | 3/133 (2.3) | 1/89 (1.1) | 1/31 (3.3) | 1/13 (7.7) | NS |
| Late deaths | 3/154 (1.9) | 2/105 (1.9) | 0/31 (0) | 1/13 (7.7) | NS |
| *Coronary-related AE | 5/133 (3.7) | 3/89 (3.3) | 1/31 (3.2) | 1/13 (7.7) | NS |
| Overall deaths | 5/138 (3.6) | 2/91 (2.2) | 1/32 (3.1) | 2/15 (13.3) | NS |
| . | All (%) . | AORCA (%) . | AOLCA (%) . | Other (%) . | P-value . |
|---|---|---|---|---|---|
| Follow-up completeness | 138/156 (88.5) | 91/105 (86.7) | 32/35 (91.4) | 14/16 (100) | NS |
| Alive | 133/156 (86.4) | 89/105 (84.8) | 31/35 (88.6) | 13/16 (81.3) | NS |
| Lost | 18/156 (11.5) | 17/105 (16.2) | 3/35 (8.6) | 1/16 (12.5) | NS |
| Age (years) | 38 (18–54.5) | 42 (20–53)a | 25 (17–53)b | 53 (17.5–57.5) | 0.020 |
| Presence of symptoms | 24/133 (14.2) | 17/89 (19.1) | 3/31 (9.7) | 4/13 (30.8) | NS |
| Chest pain | 10/133 (7.5) | 8/89 (9.0) | 2/31 (6.5) | 0/13 (0) | NS |
| Dyspnoea | 3/133 (2.3) | 3/89 (3.4) | 0/31 (0) | 0/13 (0) | NS |
| Fatigue | 3/133 (2.3) | 2/89 (2.2) | 0/31 (0) | 1/13 (7.7) | NS |
| Syncope | 1/133 (0.8) | 0/89 (0) | 0/31 (0) | 1/13 (7.7) | NS |
| Palpitations | 1/133 (0.8) | 0/89 (0) | 1/31 (3.2) | 0/13 (0) | NS |
| Vertigo/discomfort | 1/133 (0.8) | 1/89 (1.1) | 0/31 (0) | 0/13 (0) | NS |
| Not specified | 5/133 (3.8) | 3/89 (3.4) | 0/31 (0) | 2/13 (0) | NS |
| Sport activity | 64/133 (48.1) | 45/89 (50.6) | 12/31 (38.7) | 7/13 (53.8) | NS |
| Time of follow-up (years), min–max | 2 (1–5) [0–23] | 2 (1–4)a [0–8] | 5 (2–11)b [0–23] | 1 (0–5.5) [0–9] | 0.001 |
| NYHA ≥II at follow-up | 13/133 (9.8) | 8/89 (9.0) | 3/31 (9.7) | 2/13 (15.4) | NS |
| Adverse events | 12/133 (9.0) | 7/89 (7.9) | 1/31 (3.2)a | 4/13 (30.8)b | 0.086 |
| Cardiac interventional procedure | 6/133 (4.5) | 4/89 (4.5) | 0/31 (0) | 2/13 (15.4) | NS |
| Surgical reinterventional procedure | 3/133 (2.3) | 1/89 (1.1) | 1/31 (3.3) | 1/13 (7.7) | NS |
| Late deaths | 3/154 (1.9) | 2/105 (1.9) | 0/31 (0) | 1/13 (7.7) | NS |
| *Coronary-related AE | 5/133 (3.7) | 3/89 (3.3) | 1/31 (3.2) | 1/13 (7.7) | NS |
| Overall deaths | 5/138 (3.6) | 2/91 (2.2) | 1/32 (3.1) | 2/15 (13.3) | NS |
Numbers represent median (interquartile range) for continuous variable and n (%) for categorical variable. Values in the same row that have different superscript letters are significantly different from each other.
Three coronary stenting; 1 surgical resection of intramyocardial course in 1 AOLCA; 1 automatic implantable cardioverter defibrillator implant in 1 AORCA.
AE: adverse events; AOLCA: aortic origin of left coronary artery; AORCA: aortic origin of right coronary artery; NS, not significant; NYHA: New York Heart Association.
| . | All (%) . | AORCA (%) . | AOLCA (%) . | Other (%) . | P-value . |
|---|---|---|---|---|---|
| Follow-up completeness | 138/156 (88.5) | 91/105 (86.7) | 32/35 (91.4) | 14/16 (100) | NS |
| Alive | 133/156 (86.4) | 89/105 (84.8) | 31/35 (88.6) | 13/16 (81.3) | NS |
| Lost | 18/156 (11.5) | 17/105 (16.2) | 3/35 (8.6) | 1/16 (12.5) | NS |
| Age (years) | 38 (18–54.5) | 42 (20–53)a | 25 (17–53)b | 53 (17.5–57.5) | 0.020 |
| Presence of symptoms | 24/133 (14.2) | 17/89 (19.1) | 3/31 (9.7) | 4/13 (30.8) | NS |
| Chest pain | 10/133 (7.5) | 8/89 (9.0) | 2/31 (6.5) | 0/13 (0) | NS |
| Dyspnoea | 3/133 (2.3) | 3/89 (3.4) | 0/31 (0) | 0/13 (0) | NS |
| Fatigue | 3/133 (2.3) | 2/89 (2.2) | 0/31 (0) | 1/13 (7.7) | NS |
| Syncope | 1/133 (0.8) | 0/89 (0) | 0/31 (0) | 1/13 (7.7) | NS |
| Palpitations | 1/133 (0.8) | 0/89 (0) | 1/31 (3.2) | 0/13 (0) | NS |
| Vertigo/discomfort | 1/133 (0.8) | 1/89 (1.1) | 0/31 (0) | 0/13 (0) | NS |
| Not specified | 5/133 (3.8) | 3/89 (3.4) | 0/31 (0) | 2/13 (0) | NS |
| Sport activity | 64/133 (48.1) | 45/89 (50.6) | 12/31 (38.7) | 7/13 (53.8) | NS |
| Time of follow-up (years), min–max | 2 (1–5) [0–23] | 2 (1–4)a [0–8] | 5 (2–11)b [0–23] | 1 (0–5.5) [0–9] | 0.001 |
| NYHA ≥II at follow-up | 13/133 (9.8) | 8/89 (9.0) | 3/31 (9.7) | 2/13 (15.4) | NS |
| Adverse events | 12/133 (9.0) | 7/89 (7.9) | 1/31 (3.2)a | 4/13 (30.8)b | 0.086 |
| Cardiac interventional procedure | 6/133 (4.5) | 4/89 (4.5) | 0/31 (0) | 2/13 (15.4) | NS |
| Surgical reinterventional procedure | 3/133 (2.3) | 1/89 (1.1) | 1/31 (3.3) | 1/13 (7.7) | NS |
| Late deaths | 3/154 (1.9) | 2/105 (1.9) | 0/31 (0) | 1/13 (7.7) | NS |
| *Coronary-related AE | 5/133 (3.7) | 3/89 (3.3) | 1/31 (3.2) | 1/13 (7.7) | NS |
| Overall deaths | 5/138 (3.6) | 2/91 (2.2) | 1/32 (3.1) | 2/15 (13.3) | NS |
| . | All (%) . | AORCA (%) . | AOLCA (%) . | Other (%) . | P-value . |
|---|---|---|---|---|---|
| Follow-up completeness | 138/156 (88.5) | 91/105 (86.7) | 32/35 (91.4) | 14/16 (100) | NS |
| Alive | 133/156 (86.4) | 89/105 (84.8) | 31/35 (88.6) | 13/16 (81.3) | NS |
| Lost | 18/156 (11.5) | 17/105 (16.2) | 3/35 (8.6) | 1/16 (12.5) | NS |
| Age (years) | 38 (18–54.5) | 42 (20–53)a | 25 (17–53)b | 53 (17.5–57.5) | 0.020 |
| Presence of symptoms | 24/133 (14.2) | 17/89 (19.1) | 3/31 (9.7) | 4/13 (30.8) | NS |
| Chest pain | 10/133 (7.5) | 8/89 (9.0) | 2/31 (6.5) | 0/13 (0) | NS |
| Dyspnoea | 3/133 (2.3) | 3/89 (3.4) | 0/31 (0) | 0/13 (0) | NS |
| Fatigue | 3/133 (2.3) | 2/89 (2.2) | 0/31 (0) | 1/13 (7.7) | NS |
| Syncope | 1/133 (0.8) | 0/89 (0) | 0/31 (0) | 1/13 (7.7) | NS |
| Palpitations | 1/133 (0.8) | 0/89 (0) | 1/31 (3.2) | 0/13 (0) | NS |
| Vertigo/discomfort | 1/133 (0.8) | 1/89 (1.1) | 0/31 (0) | 0/13 (0) | NS |
| Not specified | 5/133 (3.8) | 3/89 (3.4) | 0/31 (0) | 2/13 (0) | NS |
| Sport activity | 64/133 (48.1) | 45/89 (50.6) | 12/31 (38.7) | 7/13 (53.8) | NS |
| Time of follow-up (years), min–max | 2 (1–5) [0–23] | 2 (1–4)a [0–8] | 5 (2–11)b [0–23] | 1 (0–5.5) [0–9] | 0.001 |
| NYHA ≥II at follow-up | 13/133 (9.8) | 8/89 (9.0) | 3/31 (9.7) | 2/13 (15.4) | NS |
| Adverse events | 12/133 (9.0) | 7/89 (7.9) | 1/31 (3.2)a | 4/13 (30.8)b | 0.086 |
| Cardiac interventional procedure | 6/133 (4.5) | 4/89 (4.5) | 0/31 (0) | 2/13 (15.4) | NS |
| Surgical reinterventional procedure | 3/133 (2.3) | 1/89 (1.1) | 1/31 (3.3) | 1/13 (7.7) | NS |
| Late deaths | 3/154 (1.9) | 2/105 (1.9) | 0/31 (0) | 1/13 (7.7) | NS |
| *Coronary-related AE | 5/133 (3.7) | 3/89 (3.3) | 1/31 (3.2) | 1/13 (7.7) | NS |
| Overall deaths | 5/138 (3.6) | 2/91 (2.2) | 1/32 (3.1) | 2/15 (13.3) | NS |
Numbers represent median (interquartile range) for continuous variable and n (%) for categorical variable. Values in the same row that have different superscript letters are significantly different from each other.
Three coronary stenting; 1 surgical resection of intramyocardial course in 1 AOLCA; 1 automatic implantable cardioverter defibrillator implant in 1 AORCA.
AE: adverse events; AOLCA: aortic origin of left coronary artery; AORCA: aortic origin of right coronary artery; NS, not significant; NYHA: New York Heart Association.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
